Target intelligence / Profile preview

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1–Nuclear factor erythroid 2-related factor 2 protein-protein interaction (PIN1–NRF2 PPI)

Target
PIN1–NRF2 PPI
Molecular classification
Protein-protein interaction, Enzyme, Transcription factor
01

Overview

The PIN1–NRF2 protein-protein interaction is a pivotal regulatory mechanism in the cellular antioxidant defense system and a major contributor to therapeutic resistance in cancer [1, 2]. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) is a unique enzyme that recognizes phosphorylated serine or threonine residues followed by proline (pSer/Thr-Pro) and catalyzes their cis-trans isomerization, thereby inducing conformational changes in target proteins [1, 3]. In this specific interaction, PIN1 binds to the Nuclear factor erythroid 2-related factor 2 (NRF2), a master transcription factor that orchestrates the expression of numerous antioxidant and detoxifying genes [2, 4]. This isomerization stabilizes NRF2 by interfering with its recognition by E3 ubiquitin ligases, such as the Keap1-independent β-TrCP pathway, thus preventing its proteasomal degradation [4, 5]. High levels of both PIN1 and NRF2 are frequently observed in various cancers, where they cooperate to protect malignant cells from the oxidative stress induced by chemotherapy and radiation [2, 6]. Consequently, disrupting the PIN1–NRF2 axis using PIN1 inhibitors like all-trans retinoic acid (ATRA) or KPT-6566 has emerged as a promising strategy to overcome chemoresistance and enhance the efficacy of standard treatments [5, 6]. However, because PIN1 regulates a wide array of proteins involved in the cell cycle and apoptosis, therapeutic targeting must address potential safety concerns related to systemic toxicity and off-target effects [1, 3]. Sources: [1] UniProt (Q13526, Q16236); [2] Sun, X. et al. (2020) PubMed: 32433614; [3] Zhou, X. Z., & Lu, K. P. (2016) PubMed: 27338439; [4] Liang, J. et al. (2019) PubMed: 31163165; [5] Wei, Z. et al. (2015) PubMed: 26063003; [6] Urbano, A. G. et al. (2019) PubMed: 30861164.

Other names
PIN1-NRF2 complexPIN1-NFE2L2 interactionPeptidyl-prolyl isomerase 1–Nuclear factor erythroid 2-related factor 2 interactionPIN1-NRF2 axis
02

Mechanism of action

Inhibition of PIN1-mediated prolyl isomerization of NRF2, which prevents NRF2 stabilization and promotes its degradation via the proteasome, thereby increasing cellular sensitivity to oxidative stress and chemotherapy.

03

Biological functions

Redox homeostasisProtein stability regulationOxidative stress responseCell survivalProlyl isomerization
04

Disease associations

CancerChemoresistanceRadioresistanceInflammation
05

Safety considerations

Potential off-target effects due to PIN1's pleiotropic roles in cell cycle regulation and signalingRisk of systemic toxicity in healthy tissuesPotential impact on neuroprotective pathways where PIN1 activity is beneficial (e.g., Alzheimer's disease prevention)
06

Interacting drugs

All-trans retinoic acid (ATRA)

3 more in the full profile.

07

Biomarkers

PIN1 expression levelsNRF2 nuclear localizationNAD(P)H quinone dehydrogenase 1 (NQO1) expressionHeme oxygenase 1 (HMOX1) expression

Beyond the preview

Go deeper on Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1–Nuclear factor erythroid 2-related factor 2 protein-protein interaction (PIN1–NRF2 PPI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1–Nuclear factor erythroid 2-related factor 2 protein-protein interaction (PIN1–NRF2 PPI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call